Trial
NCT01899326
Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Albert Einstein College of Medicine
Collaborators
National Cancer Institute (NCI)
Condition
DS (Durie/Salmon) Stage I Plasma Cell Myeloma
Intervention
Desipramine Hydrochloride
Why stopped
The study was stopped during the interim analysis due to low accrual after the widespread use of plerixafor for multiple myeloma in the United States.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-28